Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study

Kasiani C. Myers, Elissa Furutani, Edie Weller, +29

The Lancet Haematology

Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaHematologyClinical Epidemiology +7

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

Vanessa A. Fabrizio, Jaap Jan Boelens, Audrey Mauguen, +29

Blood Advances

Cell TherapyOptimal Fludarabine ExposureImmunologyImmunotherapyHematological Malignancy +17

Denosumab Treatment of Metastatic Giant-Cell Tumor of Bone in a 10-Year-Old Girl

Nicole Karras, Lynda E. Polgreen, Christian M. Ogilvie, +3

Journal of Clinical Oncology

Denosumab TreatmentSurgical OncologyMalignant Disease10-Year-old GirlMedicine +7

Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report

Vanessa A. Fabrizio, Christine L. Phillips, Adam Lane, +28

Blood Advances

Isolated Cns RelapseImmunologySurgeryTisagenlecleucel OutcomesImmunotherapy +16

Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia

Liora M. Schultz, Anne Eaton, Christina Baggott, +28

Journal of Clinical Oncology

A Randomized Trial of One versus Two Doses of Influenza Vaccine after Allogeneic Transplantation

Nicole Karras, Matthew Weeres, Wendy Sessions, +10

Biology of Blood and Marrow Transplantation

Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia

Amy Moskop, Lauren Pommert, Christina Baggott, +27

Blood Advances

Cell TherapyImmunodeficienciesImmunologyPharmacotherapyImmunotherapy +18

Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant

Monzr M. Al Malki, Ni‐Chun Tsai, Joycelynne Palmer, +16

Blood Advances

Gvhd Prophylaxis100-Day Acute GvhdImmunologyTransplantation MedicineImmunotherapy +14

Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium

Heather E. Stefanski, Anne Eaton, Christina Baggott, +25

Blood Advances

First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases

Weili Sun, Huaying Liu, Young Kim, +7

Journal of Hematology & Oncology